MAP Pharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$499.2M

1,164 transactions

Summary

MAP Pharmaceuticals, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $22.7MSales: $43.5M35 insiders

Date	Insider	Type	Value
2013-03-01	WARD SCOTT R	U	$50K
2015-01-25	ARMER THOMAS A(Chief Scientific Officer)	F	$26K
2013-03-01	HENWOOD GERALDINE	D	$0
2013-03-01	HENWOOD GERALDINE	D	$0
2013-03-01	HENWOOD GERALDINE	D	$0
2013-03-01	OSHEA WILLIAM J	D	$0
2013-03-01	WARD SCOTT R	D	$0
2013-03-01	WARD SCOTT R	D	$0
2013-03-01	WARD SCOTT R	D	$0
2013-03-01	WARD SCOTT R	D	$0
2013-03-01	WARD SCOTT R	D	$0
2013-03-01	Wolff Henry Ward	D	$0
2013-03-01	Wolff Henry Ward	D	$0
2013-03-01	Wolff Henry Ward	D	$0
2013-03-01	Wolff Henry Ward	D	$0
2013-03-01	Wolff Henry Ward	D	$0
2013-03-01	Borland Scott(SVP, Neurology Franchise)	D	$0
2013-03-01	Borland Scott(SVP, Neurology Franchise)	D	$0
2013-03-01	Borland Scott(SVP, Neurology Franchise)	D	$0
2013-03-01	Borland Scott(SVP, Neurology Franchise)	D	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

MAP Pharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope